CHICAGO, Nov. 11, 2016 (GLOBE NEWSWIRE) - The Female Health Company/Veru Healthcare (NASDAQ:FHCO) today announced that it has accepted an invitation from the U.S. Food and Drug Administration (FDA) to present at the Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee on December 6, 2016. The FDA uses advisory committees to obtain independent ... Continue reading "The Female Health Company/Veru Healthcare Invited to Present at FDA Advisory Committee Meeting on December 6, 2016"